The microbiome of a woman's reproductive tract may predict preterm birth

19-Aug-2015 - USA

The microbiomes in the reproductive tracts of pregnant women who later had a baby born too soon are significantly different from those of women who delivered full term.

Researchers at the March of Dimes Prematurity Research Center at Stanford University took weekly samples of the microorganisms from the teeth and gums, saliva, reproductive tract, and stool from 49 pregnant women. They found little change in the bacterial communities in each woman, week to week at each location. But they did find that microbial communities in the reproductive tracts of women who delivered their babies too soon were different from those of women who delivered full term. Those differences were found early in the pregnancies and tended to persist throughout the pregnancies.

"These findings may help us screen women and identify and predict those who are more likely to have a baby born too soon," said David Relman, MD, a professor of microbiology, immunology, and of medicine at the Stanford University School of Medicine and the lead investigator for the research center on this project.

Preterm birth is the number one killer of newborns and serious gaps exist between racial and ethnic groups. Worldwide, 15 million babies are born preterm, and more than one million die due to complications of an early birth. Babies who survive an early birth face serious and lifelong health problems.

The researchers also found that the patterns of women's microbiomes changed immediately after they delivered their babies, and did not revert back to pre-pregnancy patterns in some cases until at least a year later.

"This might explain why women with closely spaced pregnancies have a higher risk of preterm birth," said Dr. Relman.

Original publication

Other news from the department science

Most read news

More news from our other portals

Last viewed contents

QIAGEN and ActiveSight Sign Co-Marketing Agreement Targeting Protein Crystallography

U.S. Development Partner Quest Diagnostics Completes Clinical Development of Septin9 Colorectal Cancer Blood Test

Global Pharmaceutical companies expect hard price competition in the rising Biosimilars segment - Bi-annual survey among more than 80 executives from globally active pharmaceutical companies based in 16 countries and spread over four continents

Metobolomics uncovers key indicators of nonalcoholic fatty liver disease - Impaired oxidation in liver associated with progression to NASH

Converting carbon dioxide into useful chemicals with the help of bacteria and solar power - How electrolysis and fermentation can be combined in one system

Converting carbon dioxide into useful chemicals with the help of bacteria and solar power - How electrolysis and fermentation can be combined in one system

Agilent Technologies Presents Thought Leader Award to Lipidomics Expert Dr. Jules Griffin - Cambridge Researcher to Further Studies of Obesity, Fatty Liver Disease

3D images display plant organs down to the smallest detail - Intelligent software for a better understanding of plant tissue development

3D images display plant organs down to the smallest detail - Intelligent software for a better understanding of plant tissue development

Antibiotic treatment increases the severity of asthma in young mice

Children with rare, incurable brain disease improve after gene therapy

'An underutilized tool:' UV-LED lights can kill coronaviruses and HIV with the flip of a switch - A Toronto-based start-up company that partnered for the study, is developing unique UV-LED lighting modules

'An underutilized tool:' UV-LED lights can kill coronaviruses and HIV with the flip of a switch - A Toronto-based start-up company that partnered for the study, is developing unique UV-LED lighting modules

Research ushers in new era of boutique chocolate

New, old science combine to make faster medical test